See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.81▲ 0.20%Gold spot3,994▼ 0.75%WTI101.02▼ 2.18%
← 328130 page
XStocksXray
Market X-Ray report · 23 October 2026

Lunit Inc. (328130)

KOSDAQ · Korea · prices in KRW · close of 23 Oct 2026

Key indicators

Last closeKRW 11,300.00
52-week range8,180.00 – 24,900.00
Return, 1 month / 3 months+15.2% / +14.8%
Return, 1 year / 3 years−38.6% / −64.8%
TrendBelow its 200-day average
RSI (14)53
Volatility (1 year)79.1%
Worst drawdown (1 year)-64.2%
Average daily value traded7,040.93M KRW
Dividend yield–

Market X-Ray price-based

47/ 100 · High confidence · ahead of 42% of stocks on this exchange
Trend32
Momentum46
Stability (higher is calmer)35
Liquidity90
Income–

Five-year price chart navy: price · brown: 200-day average

1,14315,65330,16344,67359,1832022-072023-082024-082025-092026-10

About the company

Lunit Inc. is a medical software company based in Seoul, South Korea, that develops artificial intelligence tools for analysing medical images. Its products help radiologists read mammograms and chest X-rays, flagging suspicious areas for closer review. The company works with hospitals and healthcare providers that use imaging in cancer screening and diagnosis, and it also offers software for research and clinical use. Its tools are designed to fit into existing radiology workflows.

On this site Lunit Inc. appears as a stock on the KOSDAQ (Korea), code 328130, with prices in South Korean won (KRW). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Lunit Inc. (328130) trades on the KOSDAQ in Korea. It last closed at KRW 11,300.00 on 23 October 2026.

Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 1,054 of 1,832 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 38.6% and over the last three months it rose 14.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Lunit Inc. (328130)

The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ

Lens and metricValueScoreReading
Trend32 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-23.4%
From 52-week high-53.9%
Momentum46 · WeakLagging most stocks on this exchange.
3-month return14.8%
6-month return-36.8%
12-month return, skipping the last month-46.7%
Stability (higher is calmer)35 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)79.1%
Worst drawdown, 1 year (smaller is calmer)-64.2%
Liquidity90 · StrongTrades actively.
Average daily value traded7,040.93M KRW
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−4.6%
1 month+15.2%
3 months+14.8%
6 months−36.8%
1 year−38.6%
3 years−64.8%
5 years–

Signals

50-day / 200-day average10,097.40 / 14,743.67
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)936.75

Technical summary

DailyNeutral7 bullish · 4 neutral · 5 bearish
WeeklyBearish4 bullish · 1 neutral · 7 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 26 Oct 2026